{"result": "Here is a comprehensive summary of the data:\n\nHER2 is a human epidermal growth factor receptor 2, a biomarker for breast cancer. It is a protein receptor that is often overexpressed in breast cancer, with an estimated prevalence of 25-35% in inflammatory breast cancer (IBC). HER2 is a target for breast cancer treatment, and its overexpression is associated with poor prognosis. The protein receptor is targeted by various therapies, including trastuzumab, lapatinib, pertuzumab, and T-DM1, among others. HER2 is also a predictive marker for the efficacy of trastuzumab addition in breast cancer treatment. Additionally, HER2 is a receptor that can dimerize with other ligands HER receptors and is associated with PD-L1 expression in breast cancer. HER2 status refers to the human epidermal growth factor receptor 2 status, which is an important factor in determining the effectiveness of breast cancer treatment. Overall, HER2 is a critical protein receptor in breast cancer, and its expression and targeting are crucial in the development of effective treatment strategies.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we the have full context.\n\n#######\n-Data-\nEntities: \"\\\"HER2\\\"\"\nDescription List: [\"\", \"\\\"HER2 is a concept related to breast cancer and was studied in the presented research.\\\"\", \"\\\"HER2 is a human epidermal growth factor receptor 2, a biomarker for breast cancer.\\\"\", \"\\\"HER2 is a human epidermal growth factor receptor 2.\\\"\", \"\\\"HER2 is a protein expressed in breast cancer, with implications for treatment.\\\"\", \"\\\"HER2 is a protein overexpressed in IBC, with an estimated prevalence of 25-35%.\\\"\", \"\\\"HER2 is a protein receptor targeted by trastuzumab and lapatinib in breast cancer treatment.\\\"\", \"\\\"HER2 is a protein receptor that is a predictive marker for the efficacy of trastuzumab addition.\\\"\", \"\\\"HER2 is a protein receptor that is a target for breast cancer treatment.\\\"\", \"\\\"HER2 is a protein receptor that is often overexpressed in breast cancer.\\\"\", \"\\\"HER2 is a protein receptor that is overexpressed in some breast cancers and is targeted by certain therapies.\\\"\", \"\\\"HER2 is a protein that is a target for cancer therapy in IBC patients.\\\"\", \"\\\"HER2 is a protein that is amplified in breast cancer.\\\"\", \"\\\"HER2 is a protein that is often targeted in breast cancer treatment.\\\"\", \"\\\"HER2 is a protein that is targeted by anti-HER2 therapy.\\\"\", \"\\\"HER2 is a protein that is targeted by pertuzumab and trastuzumab.\\\"\", \"\\\"HER2 is a receptor that can dimerize with other ligands HER receptors.\\\"\", \"\\\"HER2 is a receptor that is associated with PD-L1 expression in breast cancer.\\\"\", \"\\\"HER2 is a receptor that is targeted by T-DM1.\\\"\", \"\\\"HER2 refers to a protein overexpressed in HER2-positive breast cancer.\\\"\", \"\\\"HER2 refers to a protein receptor that is a target for breast cancer treatment.\\\"\", \"\\\"HER2 refers to a protein receptor that is a target for targeted therapy in IBC patients.\\\"\", \"\\\"HER2 refers to human epidermal growth factor receptor 2 status.\\\"\", \"\\\"HER2 refers to human epidermal growth factor receptor 2.\\\"\", \"\\\"HER2 refers to the human epidermal growth factor receptor 2.\\\"\"]\n#######\nOutput:\n", "parameters": {"model": "llama3-8b-8192", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": null}}